Cited by 177Herpesvirus Infections and TreatmentsCytomegalovirus and herpesvirus researchNeonatal and Maternal Infections

A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery.

Watts, D.Heather, Brown, Zane A., Money, Deborah, Selke, Stacy, Huang, Meei Li, Sacks, Stephen L., Corey, Lawrence·2003·American Journal of Obstetrics and Gynecology

Abstract

Objective The purpose of this study was to assess the efficacy of acyclovir in the reduction of herpes simplex virus culture and polymerase chain reaction positivity and cesarean delivery.Study design Women with recurrent genital herpes simplex virus were randomized to acyclovir 400 mg three times daily or placebo from 36 weeks of gestation until delivery. A subset of daily specimens for herpes simplex virus culture and DNA polymerase chain reaction was self-collected. Analyses used chi(2), Fisher exact, and Mann-Whitney U tests.Results Lesions occurred at delivery among 11 of 78 women (14%) who received placebo and 4 of 84 women (5%) who received acyclovir (P =.08). Herpes simplex virus culture and polymerase chain reaction positivity near delivery occurred in 7% and 34% women in the placebo group and 0 and 2% in the acyclovir group (P =.03 and <.01, respectively). Cesarean delivery for herpes simplex virus occurred in 8 of the women (10%) in the placebo group and in 3 of the women (4%) in the acyclovir group (P =.17). Despite reductions in herpes simplex virus detection, 6% of the women who received acyclovir had herpes simplex virus detected by polymerase chain reaction on >20% of days. Neonatal outcomes were similar between groups.Conclusion Acyclovir significantly reduced, but did not eliminate, herpes simplex virus lesions and detection in late pregnancy.

Integrity signals

Registry

Crossref · 10.1067/mob.2003.185

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Suppressive acyclovir treatment starting at 36 weeks' gestation reduces the frequency of cesarean delivery among women who have recurrent genital herpes by diminishing the frequency of recurrences at term.

    “Suppressive acyclovir treatment starting at 36 weeks’ gestation reduces the frequency of cesarean delivery among women who have recurrent genital herpes by diminishing the frequency of recurrences at term (521–523).”

    From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [522]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Watts, D. H., Brown, Z. A., Money, D., Selke, S., Huang, M. L., Sacks, S. L., & Corey, L.
Affiliations
  • University of Washington (US)
  • Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa (ZA)
Venue
American Journal of Obstetrics and Gynecology
Publisher
Elsevier BV
Published
2003-03
Volume
188
Issue
3
Pages
836-843
ISSN
0002-9378 (ISSN-L)
OpenAlex
W2033358877
Cited by
177
References
25
Citations by year
2026: 8 · 2025: 3 · 2024: 5 · 2023: 5 · 2022: 3 · 2021: 4 · 2020: 6 · 2019: 2 · 2018: 5 · 2017: 11 · 2016: 6 · 2015: 8 · 2014: 13 · 2013: 8 · 2012: 5
FWCI
8.89
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Obstetrics and Gynecology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Allergy and Infectious Diseases (P01AI030731, P01-AI30731)
Topics
  • Health Sciences › Medicine › Epidemiology › Herpesvirus Infections and Treatments
  • Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Neonatal and Maternal Infections
Keywords
acyclovir, herpes simplex virus, recurrent genital herpes, late pregnancy, cesarean section, viral shedding, neonatal outcomes, antiviral prophylaxis
MeSH terms
Acyclovir, Adult, Antiviral Agents, Cesarean Section, Double-Blind Method, Female, Follow-Up Studies, Herpes Genitalis, Humans, Placebos, Pregnancy, Pregnancy Complications, Infectious, Pregnancy Outcome, Pregnancy Trimester, Third, Virus Shedding, Simplexvirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review